Carole Minker Selected Research

lupulon

7/2011	Lupulone triggers p38 MAPK-controlled activation of p53 and of the TRAIL receptor apoptotic pathway in human colon cancer-derived metastatic cells.
10/2010	p53 Activates Either Survival or Apoptotic Signaling Responses in Lupulone-Treated Human Colon Adenocarcinoma Cells and Derived Metastatic Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carole Minker Research Topics

Disease

3	Colonic Neoplasms (Colon Cancer) 01/2015 - 10/2010
2	Neoplasms (Cancer) 01/2015 - 01/2012
1	Colorectal Neoplasms (Colorectal Cancer) 01/2015
1	Leukemia 01/2012
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2012

Drug/Important Bio-Agent (IBA)

2	lupulonIBA 07/2011 - 10/2010
1	Proanthocyanidins (Procyanidins)IBA 01/2015
1	Caspase 8 (Caspase-8)IBA 01/2015
1	Caspase 9IBA 01/2015
1	PolyphenolsIBA 01/2012
1	CaspasesIBA 01/2012
1	Caspase 3 (Caspase-3)IBA 01/2012
1	Cyclin B1IBA 01/2012
1	Death Domain ReceptorsIBA 07/2011
1	p38 Mitogen-Activated Protein KinasesIBA 07/2011

Therapy/Procedure

1	Chemoprevention 01/2015